Juvenile Idiopathic Arthritis Clinical Trials in Washington D.C., District of Columbia
2 recruitingWashington D.C., District of Columbia
Showing 1–2 of 2 trials
Recruiting
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
FibromyalgiaSystemic Lupus ErythematosusJuvenile Idiopathic Arthritis
Children's National Research Institute90 enrolled1 locationNCT04833465
Recruiting
Phase 3
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
Juvenile Idiopathic Arthritis
AbbVie90 enrolled44 locationsNCT05609630